Skip to main content

Search
Profile

Phoenix A. Ho, MD

|
Phoenix A. Ho, MD

Hematology-Oncology

On staff since July 2009

Academic Title: Acting Assistant Professor

"Children are remarkable people; it's an honor to take care of them and witness the strength, spirit, resilience and sense of humor with which they face adversity. At Children's, I'm privileged to be part of a comprehensive team, all working together to provide excellent care for our patients and their families during difficult times."

Overview

Board Certification(s)
Pediatrics
Pediatric Hematology-Oncology
Medical/Professional School
Northeastern Ohio Universities College of Medicine, Rootstown
Residency
Pediatrics, Yale-New Haven Hospital , New Haven
Fellowship
Hematology, University of Washington School of Medicine, Seattle

Awards and Honors

Award NameAward DescriptionAwarded ByAward Date
ALSF Young Investigator AwardAlex's Lemonade Stand FoundationJuly 1, 2012 - June 30, 2014
MCSF AML Research AwardMary Claire Satterly FoundationJan. 1, 2010
Young Investigator Award - Journal of Clinical OncologyJournal of Clinical Oncology Jan. 1, 2009
Alex's Lemonade Stand Foundation Young InvestigatorAlex's Lemonade Stand Foundation

Publications

The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group.
Pediatric blood & cancer , 2014 Jan: 61(1)81-8
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.
British journal of haematology , 2013 Sep: 162(5)670-7
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Blood , 2012 Aug 23: 120(8)1581-8
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood , 2012 Apr 19: 119(16)3705-11
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood , 2011 Oct 27: 118(17)4561-6
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
Pediatric blood & cancer , 2011 Aug: 57(2)204-9
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2011 Feb 20: 704-11
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Blood , 2010 Dec 16: 5638-49
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood , 2010 Aug 5: 702-10
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
Blood , 2010 Mar 25: 2372-9
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood , 2009 Jun 25: 6558-66

Research Funding

Grant TitleGrantorAmountAward Date
Exploiting WT1 Genomic Alterations for Target Identification and Minimal Residual Disease Monitoring in Pediatric AML Alex's Lemonade Stand Foundation $$50,000 (annual)July 1, 2012 - June 30, 2014
SHIP and WT1 alterations as markers of PI3K/Akt activation in pediatric AMLMary Claire Satterly Foundation $50,000.00Nov. 1, 2010
Implications of s-SHIP Expression and SHIP Alterations in AMLUniversity of Washington Child Health Research Center $240,000.00July 1, 2009
Implications of s-SHIP Expression and SHIP Alterations in AMLAmerican Society of Clinical Oncology Cancer Foundation $50,000.00July 1, 2009

Primary Office

Seattle Children's
MB.8.501 - Hematology-Oncology
4800 Sand Point Way NE
Seattle, WA 98105
206-987-2106

Find a Doctor or Researcher

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

Doctor or Researcher Name:

More search options